Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Water, J. Turchany, P. Leung, J. Lake, S. Munoz, C. Surh, R. Coppel, A. Ansari, Y. Nakanuma, M. Gershwin (1993)
Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2.The Journal of clinical investigation, 91 6
ciward Wong (2004)
Laboratory Testing: Can We Get Physicians to Focus on Outcome?
M. Werner (1995)
A model for medical decision making and problem solving.Clinical chemistry, 41 8 Pt 2
M. Molitch, J. Barr, P. Callahan, R. Campbell, L. Delahanty, R. Rizza, C. Tobin, D. Young (1994)
Self-monitoring of blood glucoseDiabetes Care, 17
K. Horn, M. Castiñeiras, J. Ortola, R. Kock, F. Perriard, S. Bittner, J. Pairet, P. Ers, J. Boulanger, S. Zeidner (1991)
The determination of thyroxine and thyroxine uptake with new homogeneous enzyme immunoassays using Boehringer Mannheim/Hitachi analysis systems.European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies, 29 10
G. Umpierrez, N. Watts, L. Phillips (1995)
Clinical Utility of β3-Hydroxybutyrate Determined by Reflectance Meter in the Management of Diabetic KetoacidosisDiabetes Care, 18
M. Surks, I. Chopra, C. Mariash, J. Nicoloff, D. Solomon (1990)
American Thyroid Association guidelines for use of laboratory tests in thyroid disorders.JAMA, 263 11
Ulla Feldt-Rasmussen (1996)
Analytical and clinical performance goals for testing autoantibodies to thyroperoxidase, thyroglobulin, and thyrotropin receptor.Clinical chemistry, 42 1
S. Genuth (1997)
Diabetic ketoacidosis and hyperglycemic hyperosmolar coma.Current therapy in endocrinology and metabolism, 6
MD Siperstein (1992)
Diabetic ketoacidosis and hyperosmolar comaEndocrinol Metab Clin North Am, 21
M. Guida, R. Marger, A. Papp, P. Snyder, M. Sedra, J. Kissel, J. Mendell, T. Prior (1995)
A molecular protocol for diagnosing myotonic dystrophy.Clinical chemistry, 41 1
J. Kaneko, M. Kawamoto, A. Heusner, E. Feldman, I. Koizumi (1992)
Evaluation of serum fructosamine concentration as an index of blood glucose control in cats with diabetes mellitus.American journal of veterinary research, 53 10
ET Wong (1995)
Improving laboratory testing: can we get physicans to focus on outcome?Clin Chem, 41
(1995)
An immuno - radiometric assay for canine thyroid stimulati . ng hormone
M. Kawamoto, J. Kaneko, A. Heusner, E. Feldman, I. Koizumi (1992)
Relation of fructosamine to serum protein, albumin, and glucose concentrations in healthy and diabetic dogs.American journal of veterinary research, 53 5
(1994)
Position statement : standards of medical care for patients with diabetes mellitus
C. Spencer, M. Takeuchi, M. Kazarosyan (1996)
Current status and performance goals for serum thyrotropin (TSH) assays.Clinical chemistry, 42 1
The changing environment in the medical biochemistry arena as a result of new and concerted pressures for cost containment will have and is having its inevitable effect on the field of animal clinical biochemistry. The animal clinical biochemist must be acutely aware of the changes engendered by these pressures and be prepared to respond in a meaningful way. First and foremost, the animal clinical biochemist must be positioned as a scientist with a unique capability to cross disciplinary lines as befits the needs to understand interspecies nuances. As a corollary, there is a need for the animal clinical biochemist to not only keep abreast of new developments but to be a generator of new knowledge in the field. This then implies that research and dissemination of new knowledge is an inherent responsibility of those in the field. In this way, the animal clinical biochemist is positioned as an independent scientist/principal investigator in a broad range of studies involving animals. This further implies that animal clinical biochemists must broaden their knowledge of clinical medicine to be able to converse freely in the “language of medicine”. Numerous new vistas are described and which can be exploited to advance the field and the scope of activities for animal clinical biochemists. Among these are the Point-of-Care systems, new approaches to diabetes management, thyroid disease, autoimmune disease and tumour markers. The list of additional areas is extensive; markers of inflammation, markers of nutritional disease or deficiency, DNA probes in inherited disease, DNA probes of infectious disease. All of these areas are ripe for new ideas and advances in knowledge needing only the imaginative efforts of the animal clinical biochemist.
Comparative Clinical Pathology – Springer Journals
Published: Sep 10, 2004
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.